150 k€ in ERDF Funds granted to BioCydex

BioCydex has been awarded 150 k€ in the final development of Vectisol®, which will fund collaboration with INSERM Laboratory (UMR 1082, Ischemia, Reperfusion  & organ Transplantation) to expand high quality preclinical trials in the field of kidney transplantation.